ArticleIrish journal of medical science2025
The relationship between osteoporosis and sarcopenia parameters in postmenopausal women under 60 years of age: A cross-sectional study.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sarcopenia risk in women with postmenopausal osteoporosis: a SARC-F-based assessment.Turkish journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to determine the prevalence of sarcopenia in postmenopausal women under the age of 60 and to evaluate the relationship between sarcopenia, bone mineral density (BMD), and clinical parameters. MATERIALS AND
methodsThis cross-sectional study included 52 postmenopausal women under the age of 60, classified as osteoporotic or non-osteoporotic based on DXA results. Sarcopenia was assessed using the criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2). Muscle strength was measured using handgrip strength and the five-time sit-to-stand test (5STS), and muscle mass was assessed with the Tanita BC-418MA device. Skeletal muscle mass indices (SMMI) were calculated based on height
resultsFat-free mass (FFM), skeletal muscle mass (SMM), and SMM/height
conclusionIn our study, sarcopenia prevalence did not significantly differ between osteoporotic and non-osteoporotic postmenopausal women under 60. However, the lower muscle mass observed in the osteoporotic group may indicate early structural changes associated with sarcopenia. The lack of difference in functional capacity suggests that these changes may not yet be clinically apparent.
Indexed as
Identifiers
40982103What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.